By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ultragenyx Pharmaceuticals 

77 Digital Drive
Suite 210
Novato  California  94949  U.S.A.
Phone: 415-884-0223 Fax: 415-884-0562



Company News
Ultragenyx (RARE), Kyowa Hakko Kirin And Kyowa Kirin International Announce Positive 24-Week Data From Adult Phase II Study Of Burosumab (KRN23) In X-Linked Hypophosphatemia 4/19/2017 10:39:10 AM
Ultragenyx (RARE) Appoints Deborah Dunsire, M.D., To Board Of Directors 4/10/2017 10:38:57 AM
Bay Area's Ultragenyx (RARE) Tanks as Seizure Drug Flunks Phase II Test 3/23/2017 5:43:08 AM
Bay Area's Ultragenyx (RARE) Shelves Plan for a Quick Approval for Rare Disease Drug in Europe 11/11/2016 7:00:36 AM
Ultragenyx (RARE) Rising on Phase III Acute Myeloid Leukemia Data 7/15/2016 6:32:40 AM
10 Biotech Stocks that Could Blow Up in Q3 7/6/2016 6:56:11 AM
Ultragenyx (RARE) Forges $65 Million Rare Disease Pact with Takeda (TKPYY) 6/10/2016 11:47:02 AM
Nine Bay Area Biotechs Vie to be the “Next Genentech (RHHBY)” 5/24/2016 6:33:42 AM
Ultragenyx (RARE) Funds Saint Louis University Researcher's Quest To Treat His Daughter's Disease 3/23/2016 3:07:18 PM
Ultragenyx (RARE) To Present At The Oppenheimer Annual Healthcare Conference 12/3/2015 8:43:48 AM